1985 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Ugo Nocentini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Assessing measurement invariance of MSQOL-54 across Italian and English versions

Giordano, A., Testa, S., Bassi, M., Cilia, S., Bertolotto, A., Quartuccio, M. E., Pietrolongo, E., Falautano, M., Grobberio, M., Niccolai, C., Allegri, B., Viterbo, R. G., Confalonieri, P., Giovannetti, A. M., Cocco, E., Grasso, M. G., Lugaresi, A., Ferriani, E., Nocentini, U., Zaffaroni, M. & 4 others, De Livera, A., Jelinek, G., Solari, A. & Rosato, R., 2019, In : Quality of Life Research.

Research output: Contribution to journalArticle

Can personality traits influence occupational stress in multiple sclerosis patients? A one-year longitudinal study

Incerti, C. C., Argento, O., Magistrale, G., Di Battista, G., Ferraro, E., Caltagirone, C., Pisani, V. & Nocentini, U., Jan 1 2019, In : Applied Neuropsychology:Adult.

Research output: Contribution to journalArticle

  • Disruption of neurite morphology parallels MS progression

    Spano, B., Giulietti, G., Pisani, V., Morreale, M., Tuzzi, E., Nocentini, U., Francia, A., Caltagirone, C., Bozzali, M. & Cercignani, M., Nov 1 2018, In : Neurology: Neuroimmunology and NeuroInflammation. 5, 6, e502.

    Research output: Contribution to journalArticle

    Open Access
  • Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    EXPAND Clinical Investigators, Mar 31 2018, In : The Lancet. 391, 10127, p. 1263-1273 11 p.

    Research output: Contribution to journalArticle